Matches in Wikidata for { <http://www.wikidata.org/entity/Q91822371> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q91822371 description "artículu científicu espublizáu en mayu de 2019" @default.
- Q91822371 description "scientific article published on 01 May 2019" @default.
- Q91822371 description "wetenschappelijk artikel" @default.
- Q91822371 description "наукова стаття, опублікована 1 травня 2019" @default.
- Q91822371 description "գիտական հոդված հրատարակված 2019 թվականի մայիսի 1-ին" @default.
- Q91822371 name "Cardiovascular Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes" @default.
- Q91822371 name "Cardiovascular Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes" @default.
- Q91822371 type Item @default.
- Q91822371 label "Cardiovascular Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes" @default.
- Q91822371 label "Cardiovascular Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes" @default.
- Q91822371 prefLabel "Cardiovascular Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes" @default.
- Q91822371 prefLabel "Cardiovascular Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes" @default.
- Q91822371 P1433 Q91822371-E38A899D-6C61-4FD6-86AC-2ADCAC2104FF @default.
- Q91822371 P1476 Q91822371-DC6C48CA-7027-441A-9512-3D75253CB7A9 @default.
- Q91822371 P304 Q91822371-5ABC239E-DB1F-4341-86FE-0449BD94418D @default.
- Q91822371 P31 Q91822371-47BD9EEF-1084-4838-BAA8-A10070423351 @default.
- Q91822371 P356 Q91822371-416CC3AF-E9EF-4EBE-A68F-D3FF27A68E28 @default.
- Q91822371 P407 Q91822371-F667A2A1-2189-4F71-A667-8903469BE249 @default.
- Q91822371 P433 Q91822371-92879CDA-197B-4602-B1EF-98476EB368BE @default.
- Q91822371 P478 Q91822371-B30CEF7F-6B97-4CD0-BF14-3404BB0A1955 @default.
- Q91822371 P577 Q91822371-C9D544E4-96CF-4C71-BAD2-4BAAABCF31AB @default.
- Q91822371 P698 Q91822371-7AF86D74-0E6F-47A1-9118-3738264AF13D @default.
- Q91822371 P921 Q91822371-D94EF8D9-5EDF-4EE7-9D94-E30AE6CAD554 @default.
- Q91822371 P356 JAMA.2019.2702 @default.
- Q91822371 P698 31063571 @default.
- Q91822371 P1433 Q1470970 @default.
- Q91822371 P1476 "Cardiovascular Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes" @default.
- Q91822371 P304 "1720-1721" @default.
- Q91822371 P31 Q13442814 @default.
- Q91822371 P356 "10.1001/JAMA.2019.2702" @default.
- Q91822371 P407 Q1860 @default.
- Q91822371 P433 "17" @default.
- Q91822371 P478 "321" @default.
- Q91822371 P577 "2019-05-01T00:00:00Z" @default.
- Q91822371 P698 "31063571" @default.
- Q91822371 P921 Q3025883 @default.